Sumitomo Mitsui DS Asset Management’s Royalty Pharma RPRX Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.6M	Buy	206,765 +63,887	+45%	+$3.33M	0.08%	192
2026 Q1	$6.85M	Buy	142,878 +99,591	+230%	+$4.36M	0.06%	259
2025 Q4	$1.67M	Buy	43,287 +255	+0.6%	+$9.72K	0.01%	556
2025 Q3	$1.52M	Buy	43,032 +402	+0.9%	+$14.6K	0.01%	567
2025 Q2	$1.54M	Buy	42,630 +832	+2%	+$27.6K	0.01%	551
2025 Q1	$1.3M	Buy	41,798 +13,615	+48%	+$432K	0.01%	573
2024 Q4	$719K	Hold	28,183	–	–	0.01%	670
2024 Q3	$797K	Hold	28,183	–	–	0.01%	655
2024 Q2	$743K	Buy	28,183 +12	+0%	+$333	0.01%	647
2024 Q1	$856K	Sell	28,171 -56	-0.2%	-$1.65K	0.01%	623
2023 Q4	$793K	Hold	28,227	–	–	0.01%	655
2023 Q3	$766K	Sell	28,227 -64	-0.2%	-$1.9K	0.01%	614
2023 Q2	$870K	Hold	28,291	–	–	0.01%	594
2023 Q1	$1.02M	Buy	28,291 +6,377	+29%	+$236K	0.02%	540
2022 Q4	$866K	Hold	21,914	–	–	0.02%	550
2022 Q3	$881K	Buy	21,914 +2,665	+14%	+$114K	0.02%	523
2022 Q2	$809K	Hold	19,249	–	–	0.02%	535
2022 Q1	$750K	Hold	19,249	–	–	0.02%	579
2021 Q4	$767K	Buy	19,249 +11,216	+140%	+$436K	0.02%	586
2021 Q3	$290K	Sell	8,033 -54	-0.7%	-$2.1K	0.01%	716
2021 Q2	$331K	Hold	8,087	–	–	0.01%	711
2021 Q1	$352K	Buy	8,087 +1,731	+27%	+$82.1K	0.01%	688
2020 Q4	$318K	Buy	+6,356	New	+$270K	0.01%	685

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's RPRX Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Royalty Pharma (RPRX) stake by 45% in Q2 2026, buying an estimated $3.33M and bringing the position to 206,765 shares worth $11.6M. The position accounts for 0.08% of the portfolio, ranked #192.

Sumitomo Mitsui DS Asset Management first reported a position in RPRX in Q4 2020 and has held it in 23 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Sumitomo Mitsui DS Asset Management held 206,765 shares of Royalty Pharma worth $11.6M as of Q2 2026.
Sumitomo Mitsui DS Asset Management bought 63,887 Royalty Pharma shares in Q2 2026, an estimated $3.33M.
Royalty Pharma made up 0.08% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #192 holding.
Sumitomo Mitsui DS Asset Management first reported a position in Royalty Pharma in Q4 2020 and has held it in 23 quarters since.
643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.